Phone: (615) 322-2318
Hypertrophic Cardiomyopathy:
Why Choose Vanderbilt
-
Recognized care
Vanderbilt Heart and Vascular Institute is among the best heart programs in the nation and the top-ranked program in Tennessee, according to U.S. News & World Report. Vanderbilt University Medical Center is ranked the No. 1 adult hospital in Tennessee.
-
Skilled clinicians
Our cardiologists are trained and board-certified in adult cardiology. Our specialists have additional board certifications in advanced heart disease, advanced imaging, cardiopulmonary exercise testing, arrhythmias, congenital heart disease, structural catheter-based intervention and cardiac surgery.
-
Seamless care, pediatrics to adult
Our team works closely with your doctors at Monroe Carell Jr. Children’s Hospital at Vanderbilt to help you transition from pediatric care to adult care. We work with your doctors to create a care plan that meets your unique health goals and needs.
-
Team approach
We follow over 300 patients with hypertrophic cardiomyopathy. Our heart specialists work closely with your primary care physician, local cardiologist and other specialists. Our specialist nurse navigator ensures that all of your providers are up-to-date to help you achieve and enjoy your best total health.
-
National referral center for complex arrhythmias
Hypertrophic cardiomyopathy and other genetic heart muscle diseases are associated with risks for atrial and ventricular arrhythmias. Our electrophysiology specialists perform complex catheter ablation for many arrhythmias that cannot be treated elsewhere. They are experts in the implantation and management of pacing and defibrillation devices.
-
Access to transplant
If heart or multi-organ transplant is the next step in your care, you’re already at the right place. We perform more heart transplants than any other program in the world, providing patients with outstanding outcomes.
-
Clinical trials
As part of an academic medical center, we offer access to some of the most promising new approaches being tested in clinical trials.
Marshall Brinkley, MD – Director
Lynne W. Stevenson, MD – Co-director
Quinn Wells, MD, PharmD – Cardiovascular Genetics
Robert Piana, MD – Interventional Cardiology
Kashish Goel, MD – Interventional Cardiology
Rebecca Hung, MD, PhD -- Cardiomyopathy
Sean Hughes, MD – Cardiac MRI
Michael Baker, MD – Echocardiography
Ashish Shah, MD – Cardiac Surgery
Jay Montgomery, MD – Electrophysiology
Mark Wigger MD – Cardiomyopathy Outreach
Katherine Anderson, MS, CSG – Genetic Counselor
Becky King, RN – Nurse Navigator
Teresa Strickland, RN, BSN – Research Nurse
Mary Sharpe – Scheduling
